168 related articles for article (PubMed ID: 1978470)
1. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
[TBL] [Abstract][Full Text] [Related]
2. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
[TBL] [Abstract][Full Text] [Related]
4. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H
Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
[TBL] [Abstract][Full Text] [Related]
5. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM
Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
[TBL] [Abstract][Full Text] [Related]
7. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
Mendlewicz J; de Bleeker E; Cosyns P; Deleu G; Lotstra F; Masson A; Mertens C; Parent M; Peuskens J; Suy E
Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
[TBL] [Abstract][Full Text] [Related]
8. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
Patris M; Agussol P; Alby JM; Brion S; Burnat G; Castelnau D; Deluermoz S; Dufour H; Ferreri M; Goudemand M
Acta Psychiatr Scand Suppl; 1990; 358():78-82. PubMed ID: 1978497
[TBL] [Abstract][Full Text] [Related]
9. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
Pflug B; Bartels M; Bauer H; Bunse J; Gallhofer B; Haas S; Kanzow WT; Klieser E; Küfferle B; Stein D
Acta Psychiatr Scand Suppl; 1990; 358():142-6. PubMed ID: 1978475
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
Lewander T; Westerbergh SE; Morrison D
Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
[TBL] [Abstract][Full Text] [Related]
12. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
[TBL] [Abstract][Full Text] [Related]
13. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
Lapierre YD; Nair NP; Chouinard G; Awad AG; Saxena B; Jones B; McClure DJ; Bakish D; Max P; Manchanda R
Acta Psychiatr Scand Suppl; 1990; 358():72-7. PubMed ID: 1978496
[TBL] [Abstract][Full Text] [Related]
14. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
Wålinder J; Holm AC
Acta Psychiatr Scand Suppl; 1990; 358():158-63. PubMed ID: 1978477
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
den Boer JA; Westenberg HG
Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
Classen W; Laux G
Neuropsychobiology; 1989; 21(3):131-40. PubMed ID: 2575719
[TBL] [Abstract][Full Text] [Related]
17. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
Chouinard G
Acta Psychiatr Scand Suppl; 1990; 358():111-9. PubMed ID: 1978469
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
Lahdelma RL; Appelberg B; Kuoppasalmi K; Katila H; Rimón R
Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
[TBL] [Abstract][Full Text] [Related]
20. Cognitive disturbances in neuroleptic therapy.
Strauss WH; Klieser E
Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
